Riluzole, an FDA-approved drug to treat ALS, can, in part, correct the molecular cause of some leukodystrophies.
Researchers combine two different imaging techniques to track the rate at which nerve fibers in the developing brain becomes wrapped in myelin.
Researchers have identified a new gene associated with 4H leukodystrophy.
